Search bioRxiv⌕ Search

bioRxiv · 10.1101/239236

DeepMHC: Deep Convolutional Neural Networks for High-performance peptide-MHC Binding Affinity Prediction

Abstract

Convolutional neural networks (CNN) have been shown to outperform conventional methods in DNA-protien binding specificity prediction. However, whether we can transfer this success to protien-peptide binding affinity prediction depends on appropriate design of the CNN architectue that calls for thorough understanding how to match the architecture to the problem. Here we propose DeepMHC, a deep convolutional neural network (CNN) based protein-peptide binding prediction algorithm for achieving better performance in MHC-I peptide binding affinity prediction than conventional algorithms. Our model takes only raw binding peptide sequences as input without needing any human-designed features and othe physichochemical or evolutionary information of the amino acids. Our CNN models are shown to be able to learn non-linear relationships among the amino acid positions of the peptides to achieve highly competitive performance on most of the IEDB benchmark datasets with a single model architecture and without using any consensus or composite ensemble classifier models. By systematically exploring the best CNN architecture, we identified critical design considerations in CNN architecture development for peptide-MHC binding prediction.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hu, J., Liu, Z.. 2017-12-24. DeepMHC: Deep Convolutional Neural Networks for High-performance peptide-MHC Binding Affinity Prediction. https://doi.org/10.1101/239236

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Cellular composition and the interpretation of candidate RNA readouts of trogocytosis in colorectal cancer

Background: RNA measurements of genes associated with trogocytosis may reflect cellular composition rather than contact-dependent membrane acquisition. We evaluated an eight-gene candidate module in colorectal cancer (CRC) using expression- and lineage-matched random modules, independent compartment analysis and patient-level inference. A separate rare-transcript definition and cancer-model fitness screens provided complementary analyses. Results: In 62 GSE178341 patients, the module correlated with T-cell fraction ({rho}=0.767), but this association was typical of 10,000 matched modules (null median 0.766; one-sided empirical P=0.493; equal-tail two-sided P=0.985). A post hoc closest-10% matching sensitivity gave P=0.571. In 23 independent GSE132465 patients, the tumour-wide correlation was 0.735 (permutation P=0.00060) and the epithelial correlation was 0.376 (P=0.0892). The difference in absolute correlations was 0.359, with a 95% confidence interval of -0.041 to 0.759, leaving attenuation uncertain. Among 43,817 leukocytes, 16 CEACAM5-positive candidates arose from four patients; 15 had expression [≤]2 transcripts per million. Candidate counts were threshold-sensitive. No survival association was detected for the module in two cohorts. SCD fitness dependency reproduced across CRC organoids and cell lines, whereas adjusted SCD-VPS72 and exploratory ATF3-SMYD2 co-dependencies did not. Exploratory CH25H, ATF3 and FADS2 analyses yielded no Hallmark enrichment meeting the multiple-testing threshold. Conclusions: Matched-module calibration placed the strong association with T-cell abundance within the range expected for comparable immune-lineage genes. Independent compartment analysis was consistent with a contribution from cellular composition, although attenuation remained uncertain. These results identify the comparison conditions needed to interpret the tested RNA readouts. Linking them to membrane transfer requires event-resolved protein measurements.

bioinformatics↗

NeuroWeave-3D: Uncertainty-Aware Evidence Completion for Brain Tumor Segmentation with Missing MRI Modalities

Multi-parametric MRI segmentation models are accurate when all prescribed sequences are available but can be brittle under missing or corrupted modalities. We propose NeuroWeave-3D, a 3D glioma segmentation framework that treats missing modalities as uncertain evidence rather than deterministic channels to reconstruct. The model combines spatial modality routing, probabilistic latent feature completion, complete-to-missing consistency, and voxel-level uncertainty estimation. A curriculum over all non-empty MRI modality subsets trains one network for arbitrary sequence availability. We define a BraTS-centered evaluation that reports complete-input accuracy, macro and worst-case missing-modality performance, corruption robustness, calibration, and failure detection.

bioinformatics↗

Differential Gene Expression and Functional Enrichment Analysis of Breast Tumor and Normal Tissue RNA-seq Data: A Reanalysis of GEO Dataset GSE210787

Background: RNA sequencing (RNA-seq) allows a global assessment of expression differences between biological states. The present study reanalyzed publicly available RNA-seq data from human breast tumors and normal tissues to identify DEGs and to investigate functional enrichment. Methods: Twelve paired-end RNA-seq samples from the GEO series GSE210787 were analyzed, including six tumor and six normal samples. Reads were obtained using the SRA Toolkit, checked with FastQC and MultiQC, trimmed with fastp, aligned to the GRCh38.p14 reference with STAR, and quantified at the gene level with featureCounts. Differential expression analysis was performed using DESeq2 in the Galaxy environment. The project report details criteria of adjusted p-value < 0.05 and absolute log2 fold change [&ge;] 1. Gene Ontology enrichment was performed using g:Profiler and KEGG overrepresentation analysis was performed separately for the up- and down-regulated gene sets. Results: The project report contains a list of 120 differentially expressed genes (DEGs), including 69 upregulated and 51 downregulated genes in tumor tissue compared with normal tissue. One upregulated-gene GO Cellular Component term, cell periphery (GO:0071944), was observed with a P-value of approximately 0.017585 and 29 overlapping genes. The original report does not specify if this P-value is nominal or adjusted. No significant GO terms were found for the down-regulated gene set. After multiple testing corrections, no KEGG pathway was significant; the lowest adjusted p-value for the upregulated group was about 0.71393. Conclusion: The project identified differences in expression between tumor and normal samples, but no KEGG pathway reached the set FDR significance threshold. The final interpretation needs to check sample metadata, DESeq2 contrast, GO significance statistic, KEGG background universe and analytical parameters against the original results. Keywords: RNA-seq; breast tumor; differential expression; DESeq2; Gene Ontology; KEGG pathway; transcriptomics; cell periphery.

bioinformatics↗